These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38242267)

  • 1. GSK343 modulates macrophage M2 polarization through the EZH2/MST1/YAP1 signaling axis to mitigate neurological damage induced by hypercalcemia in CKD mice.
    Cao Y; Sun H; Li X; Pommer W; Xiong Y; Chen X; Chu C; Yu F; Hocher B; Wang Z
    Cell Signal; 2024 Apr; 116():111063. PubMed ID: 38242267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silencing of O-linked N-acetylglucosamine transferase ameliorates hypercalcemia-induced neurotoxicity in renal failure by regulating EZH2/KLF2/CXCL1 axis.
    Cao Y; Chen X; Sun H
    Cell Death Dis; 2021 Aug; 12(9):819. PubMed ID: 34462420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancer of zeste homolog 2 promotes renal fibrosis after acute kidney injury by inducing epithelial-mesenchymal transition and activation of M2 macrophage polarization.
    Zhou X; Chen H; Hu Y; Ma X; Li J; Shi Y; Tao M; Wang Y; Zhong Q; Yan D; Zhuang S; Liu N
    Cell Death Dis; 2023 Apr; 14(4):253. PubMed ID: 37029114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of histone methyltransferase EZH2 in Schistosoma mansoni in vitro by GSK343 reduces egg laying and decreases the expression of genes implicated in DNA replication and noncoding RNA metabolism.
    Pereira ASA; Amaral MS; Vasconcelos EJR; Pires DS; Asif H; daSilva LF; Morales-Vicente DA; Carneiro VC; Angeli CB; Palmisano G; Fantappie MR; Pierce RJ; Setubal JC; Verjovski-Almeida S
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006873. PubMed ID: 30365505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effect of enhancer of Zeste homolog 2 inhibitor GSK343 on periodontitis by regulating macrophage differentiation].
    Zhongchao W; Liyuan F; Dan T; Cong Z; Shijun L
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):264-268. PubMed ID: 28675010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GSK343 induces programmed cell death through the inhibition of EZH2 and FBP1 in osteosarcoma cells.
    Xiong X; Zhang J; Li A; Dai L; Qin S; Wang P; Liu W; Zhang Z; Li X; Liu Z
    Cancer Biol Ther; 2020; 21(3):213-222. PubMed ID: 31651209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drp1 activates ROS/HIF-1α/EZH2 and triggers mitochondrial fragmentation to deteriorate hypercalcemia-associated neuronal injury in mouse model of chronic kidney disease.
    Sun H; Li X; Chen X; Xiong Y; Cao Y; Wang Z
    J Neuroinflammation; 2022 Sep; 19(1):213. PubMed ID: 36050772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three-dimensional culture sensitizes epithelial ovarian cancer cells to EZH2 methyltransferase inhibition.
    Amatangelo MD; Garipov A; Li H; Conejo-Garcia JR; Speicher DW; Zhang R
    Cell Cycle; 2013 Jul; 12(13):2113-9. PubMed ID: 23759589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fuse-binding protein 1 is a target of the EZH2 inhibitor GSK343, in osteosarcoma cells.
    Xiong X; Zhang J; Liang W; Cao W; Qin S; Dai L; Ye D; Liu Z
    Int J Oncol; 2016 Aug; 49(2):623-8. PubMed ID: 27278257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paeoniflorin suppresses kidney inflammation by regulating macrophage polarization via KLF4-mediated mitophagy.
    Cao Y; Xiong J; Guan X; Yin S; Chen J; Yuan S; Liu H; Lin S; Zhou Y; Qiu J; Wang D; Liu B; Zhou J
    Phytomedicine; 2023 Jul; 116():154901. PubMed ID: 37247587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. S-Adenosyl-L-methionine-competitive inhibitors of the histone methyltransferase EZH2 induce autophagy and enhance drug sensitivity in cancer cells.
    Liu TP; Lo HL; Wei LS; Hsiao HH; Yang PM
    Anticancer Drugs; 2015 Feb; 26(2):139-47. PubMed ID: 25203626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.
    Ihira K; Dong P; Xiong Y; Watari H; Konno Y; Hanley SJ; Noguchi M; Hirata N; Suizu F; Yamada T; Kudo M; Sakuragi N
    Oncotarget; 2017 Feb; 8(8):13509-13520. PubMed ID: 28088786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of YAP1 activity ameliorates acute lung injury through promotion of M2 macrophage polarization.
    Liang L; Xu W; Shen A; Fu X; Cen H; Wang S; Lin Z; Zhang L; Lin F; Zhang X; Zhou N; Chang J; Chen ZS; Li C; Yu X
    MedComm (2020); 2023 Jun; 4(3):e293. PubMed ID: 37287755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Histone Methyltransferase Inhibitors on the Survival, Apoptosis and Cell Cycle of Raji Cells].
    Xiao LR; Hou C; Zheng SJ; Guo B; Chen DN; Yan NH
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):305-310. PubMed ID: 31631594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (-)-Epigallocatechin-3-gallate and EZH2 inhibitor GSK343 have similar inhibitory effects and mechanisms of action on colorectal cancer cells.
    Ying L; Yan F; Williams BR; Xu P; Li X; Zhao Y; Hu Y; Wang Y; Xu D; Dai J
    Clin Exp Pharmacol Physiol; 2018 Jan; 45(1):58-67. PubMed ID: 28925507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological targeting macrophage phenotype via gut-kidney axis ameliorates renal fibrosis in mice.
    Xie Y; Hu X; Li S; Qiu Y; Cao R; Xu C; Lu C; Wang Z; Yang J
    Pharmacol Res; 2022 Apr; 178():106161. PubMed ID: 35259481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inactivation of MST1/2 Controls Macrophage Polarization to Affect Macrophage-Related Disease via YAP and Non-YAP Mechanisms.
    An Y; Tan S; Zhang P; Yang J; Wang K; Zheng R; Qiao L; Wang Y; Dong Y
    Int J Biol Sci; 2024; 20(3):1004-1023. PubMed ID: 38250155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurorescuing effect of Cinacalcet against hypercalcemia-induced nerve injury in chronic kidney disease via TRAF2/cIAP1/KLF2/SERPINA3 signal axis.
    Cao Y; Xiong Y; Sun H; Wang Z
    Cell Biol Toxicol; 2023 Oct; 39(5):1-17. PubMed ID: 35635602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.
    Gong H; Li Y; Yuan Y; Li W; Zhang H; Zhang Z; Shi R; Liu M; Liu C; Chen C; Liu H; Chen J
    BMC Cancer; 2020 Dec; 20(1):1189. PubMed ID: 33276757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of EZH2 prevents acute respiratory distress syndrome (ARDS)-associated pulmonary fibrosis by regulating the macrophage polarization phenotype.
    Bao X; Liu X; Liu N; Zhuang S; Yang Q; Ren H; Zhao D; Bai J; Zhou X; Tang L
    Respir Res; 2021 Jul; 22(1):194. PubMed ID: 34217280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.